An open-label extension study to evaluate the long-term safety and tolerability of Lu AE58054 as adjunctive treatment to donepezil in patients with mild-moderate Alzheimer's disease
-
- STATUS
- Not Recruiting
Updated on 19 February 2024
Summary
This study is designed as a classic open-label extension study with add-on design to evaluate the long-term safety and tolerability of Lu AE8054 as adjunctive therapy to donepezil in subjects with mild-moderate Alzheimer?s disease (AD).
Description
This study is designed as a classic open-label extension study with add-on design to evaluate the long-term safety and tolerability of Lu AE8054 as adjunctive therapy to donepezil in subjects with mild-moderate Alzheimer?s disease (AD).
Details
| Condition | Alzheimer's disease |
|---|---|
| Age | 100years or below |
| Clinical Study Identifier | TX4244 |
| Last Modified on | 19 February 2024 |
How understandable was the trial content above?
Hard to understand
Easy to understand
Similar trials to consider
Loading...
Not finding what you're looking for?
Sign up as a volunteer to stay informed
Every year hundreds of thousands of volunteers step forward to participate in research. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.
Sign up as volunteerStudy Definition
WikipediaAdd a private note
- Select a piece of text.
- Add notes visible only to you.
- Send it to people through a passcode protected link.